Episode Details
Back to Episodes
Gene Therapy Hope for Young Sickle Cell Patients | Nashville News
Description
FDA just approved a groundbreaking gene therapy for kids as young as two with sickle cell disease—expanding access from age 12 up. This revolutionary treatment reprograms a child’s own stem cells to produce fetal hemoglobin, slashing painful complications that once crippled young patients like 13-year-old Rickey Buggs. With traditional transplants often impossible due to donor shortages, this new therapy offers a lifeline, especially when started early to prevent lifelong damage. What once felt like sci-fi is now a reality—giving hope for healthier, pain-free futures.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/7c624bfe9954b3bc